언어 선택

BMP-10

제품 문의

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Veligrotug	ZB-001; VRDN-001; AVE-1642	Phase 3 Clinical	Viridian Therapeutics Inc	Solid tumours; Graves Ophthalmopathy; Multiple Myeloma; Breast Neoplasms	상세
Ganitumab	AMG-479	Phase 3 Clinical	Amgen Inc	Sarcoma, Ewing; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive, Peripheral; Carcinoma, Non-Small-Cell Lung; Lymphoma; Lung Neoplasms; Rhabdomyosarcoma, Alveolar; Colorectal Neoplasms; Neuroectodermal Tumors, Primitive; Prostatic Neoplasms; Breast Neoplasms; Solid tumours; Sarcoma; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Carcinoid Tumor; Rhabdomyosarcoma, Embryonal; Ovarian Neoplasms; Intestinal Neoplasms; Bone metastases; Rhabdomyosarcoma	상세
Linsitinib	OSI-906; ASP-7487; OSI-906AA	Phase 3 Clinical	Astellas Pharma Inc, National Cancer Institute	Multiple Myeloma; Paraganglioma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Orbital Diseases; Eye Diseases; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Exophthalmos; Breast Neoplasms; Prostatic Neoplasms; Sarcoma, Ewing; Adrenocortical Carcinoma; Thyroid Diseases; Graves Ophthalmopathy; Endocrine System Diseases; Skin Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Hashimoto Disease; Head and Neck Neoplasms; Ovarian Neoplasms; Carney Complex; Liver Neoplasms; Solid tumours; Chondrosarcoma	상세
Conteltinib	CT-707; SY-707	Phase 3 Clinical		Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung	상세
FPI-1434	[225Ac]-FPI-1434; FPX-01	Phase 2 Clinical	Fusion Pharma	Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Neoplasms; Adrenocortical Carcinoma; Uveal melanoma; Breast Neoplasms; Endometrial Neoplasms; Uterine Cervical Neoplasms	상세
Dalotuzumab	h7C-10; MK-0646; F-50-035	Phase 2 Clinical	Pierre Fabre Group	Solid tumours; Rectal Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Neuroendocrine Tumors; Multiple Myeloma; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung	상세
CT-102	CT-102	Phase 2 Clinical	Hangzhou Tianlong Pharmaceutical Co Ltd, Institute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences	Liver Neoplasms; Carcinoma, Hepatocellular	상세
Mecasermin Rinfabate	OHB-607; SHP-607; HGT-ROP-001; rhIGF-I/rhIGFBP-3; TAK-607	Phase 2 Clinical	Insmed	Noonan Syndrome; Failure to Thrive; Cerebral Intraventricular Hemorrhage; Bronchopulmonary Dysplasia; Myotonic Dystrophy; Retinopathy of Prematurity; Muscular Dystrophies; Laron Syndrome	상세
Insulin growth factor receptor type 1 antisense therapy (Imvax)	IGV-001	Phase 2 Clinical	Thomas Jefferson University	Glioblastoma	상세
MHB018A		Phase 2 Clinical	Minghui Pharmaceutical (Hangzhou) Co Ltd	Graves Ophthalmopathy	상세
Lonigutamab	VB-421	Phase 2 Clinical	Pierre Fabre Group	Graves Ophthalmopathy	상세
Cixutumumab	A-12; IMC-A12; LY-3012217; NSC-742460	Phase 2 Clinical	Eli Lilly And Company	Gastrinoma; Adenocarcinoma, Bronchiolo-Alveolar; Gliosarcoma; Colorectal Neoplasms; Neuroblastoma; Medullary thyroid cancer (MTC); Chondrosarcoma, Extraskeletal Myxoid; Retinoblastoma; Neurofibrosarcoma; Brain Stem Neoplasms; Lymphoma, Mantle-Cell; Breast Neoplasms; Osteosarcoma; Prostatic Neoplasms; Sarcoma; Sarcoma, Ewing; Liposarcoma; Esophageal adenocarcinoma; Neuroectodermal Tumors, Primitive, Peripheral; Adenocarcinoma; Melanoma; Paraganglioma; Breast Neoplasms, Male; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Sarcoma, Alveolar Soft Part; Adrenocortical Carcinoma; Rhabdomyosarcoma, Alveolar; Carcinoma, Neuroendocrine; Glioma; Esophageal Squamous Cell Carcinoma; Hemangiopericytoma; Lung Neoplasms; Pinealoma; Rectal Neoplasms; Carcinoma, Merkel Cell; Stomach Neoplasms; Hemangiosarcoma; Insulinoma; Hepatoblastoma; Esophageal Neoplasms; Mesenchymoma; Squamous Cell Carcinoma of Head and Neck; Rhabdomyosarcoma, Embryonal; Carcinoma; Fibrosarcoma; Kidney Neoplasms; Liver Neoplasms; Head and Nec	상세
Picropodophyllin	PPP; AXL-1717; NSC-36407	Phase 2 Clinical	Axelar Ab	Astrocytoma; Carcinoma, Non-Small-Cell Lung	상세
NNC0268-0965	NNC0268-0965	Phase 1 Clinical	Novo Nordisk A/S	Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2	상세
IGF-1 receptor oligodeoxynucleotide-based immunotherapy (Thomas Jefferson University)		Phase 1 Clinical	Sidney Kimmel Cancer Center	Glioma	상세
Insulin-Like Growth Factor 1 (Wright State Physicians)		Phase 1 Clinical	Wright State Physicians	Nasolabial fold wrinkles; Burns; Sunburn	상세
SAR-446159	ABL-301; SAR-446159	Phase 1 Clinical	Abl Bio Inc	Parkinson Disease	상세
VRDN-003	VRDN-003	Phase 1 Clinical	Viridian Therapeutics Inc	Graves Ophthalmopathy	상세
VRDN-002	VRDN-002	Phase 1 Clinical	Viridian Therapeutics Inc	Graves Ophthalmopathy	상세
LX-101 (Lirum Therapeutics)	765IGF-MTX; IGF/MTX	Phase 1 Clinical	Lirum Therapeutics Inc	Head and Neck Neoplasms; Anemia, Refractory, with Excess of Blasts; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Neoplasms; Graves Ophthalmopathy; Breast Neoplasms; Brain Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Melanoma; Gastrointestinal Neoplasms	상세
ZB-011	ZB-011; ZB011	Phase 1 Clinical	Viridian Therapeutics Inc	Graves Ophthalmopathy	상세
Teprotumumab(Zhejiang Boxiao Bio-pharma)		Phase 1 Clinical	Zhejiang Boxiao Bio-pharmaceutical Co Ltd	Graves Ophthalmopathy	상세
PHP-1003	PHP-1003; PHP1003	Phase 1 Clinical	Suzhou Pulekang Pharmaceutical Technology Co Ltd	Graves Ophthalmopathy	상세
124I-CPD-1023-figitumumab	124I-CPD-1028; 125I-CPD-1028; CPD-1028-[124I]; CPD-1028-[125I]; FPX-1028	Phase 1 Clinical	Fusion Pharma	Neoplasms	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Mecasermin (Astellas/OrphanPacific)		Approved	Astellas Pharma Inc	Somazon	Japan	Growth hormone deficiency; Diabetes Mellitus, Lipoatrophic; Dwarfism	null	1994-10-05	Diabetes Mellitus, Lipoatrophic; Heart Failure; Myocardial Infarction; Multiple Sclerosis; HIV-Associated Lipodystrophy Syndrome; Dwarfism; Growth hormone deficiency	상세
Mecasermin (Ipsen)	IGF-1; FK-780; MKN-031	Approved	Ipsen	Increlex	United States	Failure to Thrive	Ipsen Inc	2005-08-30	Failure to Thrive; Autism Spectrum Disorder; X-Linked Combined Immunodeficiency Diseases; Phelan-McDermid syndrome; Growth Disorders; Muscular Dystrophy, Duchenne; Laron Syndrome	상세
Brigatinib	AP-26113	Approved	Ariad Pharmaceuticals Inc	Alunbrig, ALUNBRIG	United States	Carcinoma, Non-Small-Cell Lung	Takeda Pharmaceuticals USA Inc	2017-04-28	Solid tumours; Ependymoma; Carcinoma; Neoplasms; Neurofibromatosis 2; Myofibroma; Lymphoma, Large-Cell, Anaplastic; Granuloma, Plasma Cell; Lung Neoplasms; Brain metastases; Carcinoma, Non-Small-Cell Lung; Sarcoma, Kaposi; Neurilemmoma; Neuroma, Acoustic; Meningioma	상세
IGF-1 (Biogen/Pharmacia & Upjohn)		Approved	Biogen Inc, Pharmacia & Upjohn	Igef	Sweden	Dwarfism	null	1994-01-01	Dwarfism	상세
Ceritinib	LDK-378; NVP-LDK378; NVP-LDK378-NX	Approved	Novartis Pharma Ag	赞可达, Zykadia	EU	Carcinoma, Non-Small-Cell Lung	Novartis Europharm Ltd	2014-04-29	Hepatic Insufficiency; Adenocarcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Brain metastases; Esophageal adenocarcinoma; Granuloma, Plasma Cell; Lymphoma, Large-Cell, Anaplastic; Thyroid Neoplasms; Hematologic Neoplasms; Colorectal Neoplasms; Cholangiocarcinoma; Neoplasms; Pancreatic Neoplasms; Glioblastoma; Thyroid Carcinoma, Anaplastic; Stomach Neoplasms	상세
Teprotumumab	R-1507; RG-1507; RO-4858696; HZN-001; RV-001（River Vision）	Approved	Genmab A/S, F. Hoffmann-La Roche Ltd	Tepezza	United States	Graves Ophthalmopathy	Horizon Therapeutics Ireland	2020-01-21	Neoplasms; Graves Ophthalmopathy; Sarcoma; Breast Neoplasms; Diabetic macular oedema; Scleroderma, Diffuse; Carcinoma, Non-Small-Cell Lung	상세